ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Recruiting

Phase 1

Sponsor:

ProDa BioTech, LLC

Code:

NCT05085548

Conditions

Advanced Pancreatic Cancer

Solid Tumor Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ProAgio Dose Levels (DL) 1,2,3

ProAgio Dose Levels (DL) 4,5,6

ProAgio Dose Levels 4a,5a,6a

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information